Nurse's Pocket Guide

Outcome: Blood Glucose Control (NOC)
Indicators: Client Will:
Demonstrate correction of metabolic state as evidenced by FBS
less than 120 mg/dL within 36 hr (6/30 0700).
ACTIONS/INTERVENTIONS RATIONALE
Hyperglycemia Management (NIC)
Perform fingerstick BG qid Bedside analysis of blood
glucose levels is a more
timely method for monitoring
effectiveness of therapy
and provides direction for
alteration of medications.
Administer antidiabetic Treats underlying metabolic
medications: dysfunction, reducing
hyperglycemia and
promoting healing.
10 U Humulin N insulin Intermediate-acting
SC q am/HS after preparation with onset of
fingerstick BG; 2–4 hr, peak 4–10 hr, and
duration 10–16 hr.
Increases transport of glucose
into cells and promotes
the conversion of
glucose to glycogen.
DiaBeta 10 mg PO BID; Lowers blood glucose by
stimulating the release of
insulin from the pancreas
and increasing the sensitivity
to insulin at the receptor
sites.
Glucophage 500 mg PO qday. Glucophage lowers serum
Note onset of side effects. glucose levels by decreasing
hepatic glucose production
and intestinal glucose
absorption, and increasing
sensitivity to insulin. By
using in conjunction with
Diabeta, client may be able
to discontinue insulin once
target dosage is achieved
(e.g., 2000 mg/day).
Increase of 1 tablet per
week is necessary to limit
side effects of diarrhea,
abdominal cramping, vomiting,
possibly leading to
56 NURSE’S POCKET GUIDE